|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 13 748,00 GBX | +1,82% |
|
+1,75% | -0,30% |
| 12/05 | L'essai de phase 3 d'AstraZeneca livre des résultats significatifs dans l'hypoparathyroïdie | MT |
| 12/05 | AstraZeneca salue les résultats de phase 3 pour son traitement de l'hypoparathyroïdie | AN |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,82% | +1,75% | -9,73% | -7,22% | -0,30% | +34,26% | +15,30% | +80,14% | +249,60% | 286 Md | |
| +2,37% | +2,27% | +5,36% | -2,50% | -7,89% | +34,76% | +127,27% | +408,28% | +1 197,17% | 862 Md | |
| +1,28% | +0,03% | -5,95% | -6,89% | +8,36% | +45,42% | +39,30% | +32,79% | +96,08% | 533 Md | |
| +2,51% | -0,14% | -0,04% | -5,90% | -9,03% | +12,60% | +41,80% | +80,92% | +231,52% | 358 Md | |
| -0,94% | -0,38% | -0,10% | -11,63% | -3,93% | +22,40% | +11,63% | +5,54% | +29,22% | 328 Md | |
| +1,93% | +1,81% | -4,81% | -5,85% | +5,75% | +27,49% | +25,19% | +46,86% | +58,23% | 279 Md | |
| +0,98% | -0,65% | -7,45% | -5,82% | +6,75% | +47,91% | -4,41% | +45,07% | +106,90% | 275 Md | |
| -1,17% | +4,79% | +23,21% | -3,33% | -8,84% | -33,27% | -48,68% | +27,46% | +65,46% | 210 Md | |
| +2,03% | +3,84% | -4,20% | -8,26% | +2,74% | +26,49% | +44,77% | +33,29% | +118,12% | 178 Md | |
| +1,06% | +1,70% | -2,91% | -13,39% | +9,94% | +39,24% | +71,46% | +100,74% | +60,83% | 166 Md | |
| +0,23% | -1,63% | -3,90% | -6,71% | +3,90% | +16,11% | -31,16% | -34,26% | -21,98% | 147 Md | |
| +1,40% | -1,62% | -3,70% | -5,81% | +4,65% | +21,53% | -18,28% | -12,15% | -20,28% | 114 Md | |
| +3,01% | +4,29% | +2,76% | -2,81% | -1,12% | +5,48% | +27,94% | +110,46% | +436,04% | 110 Md | |
| +0,19% | -5,72% | -8,52% | -11,14% | -11,32% | -21,05% | -26,02% | -13,85% | +5,57% | 104 Md | |
| +2,55% | -0,50% | -13,07% | -12,02% | +3,67% | +37,31% | +30,92% | +13,76% | +2,59% | 100 Md | |
| -2,00% | -5,47% | -10,16% | -13,61% | -5,45% | -5,17% | +120,67% | +90,84% | +531,95% | 83,36 Md | |
| +0,12% | -1,36% | -9,84% | -7,40% | +6,89% | +22,06% | +13,21% | +38,85% | +2,74% | 51,94 Md | |
| +4,84% | +4,14% | -1,66% | -4,74% | -5,81% | +6,25% | +20,85% | -19,57% | +284,06% | 52,3 Md | |
| +3,67% | +2,78% | -4,19% | -16,66% | +3,86% | +59,87% | -28,74% | -28,06% | -61,56% | 42,93 Md | |
| -0,08% | +1,30% | +16,19% | +4,37% | +14,74% | +111,52% | +336,18% | +249,37% | -29,67% | 41,73 Md | |
| Moyenne | +0,83% | -0,56% | -2,14% | -7,37% | +0,88% | +25,56% | +38,46% | +62,82% | +167,13% | 216,11 Md | |
| Moyenne pondérée par Capi. | +0,47% | -0,66% | -1,15% | -6,49% | -0,61% | +26,88% | +44,13% | +115,82% | +332,42% |
- Bourse
- Actions
- Action AZN
- Secteur AstraZeneca PLC
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Zonebourse is also available in this country: United States.
Switch edition
Rester sur l'édition actuelle